Table of contents
General:
books
FDA cleared or approved companion diagnostic devices
Sites with companion diagnostic testing algorithms: breast colorectal (pending) gastric & esophageal (pending) lung ovary (pending) skin (melanoma) (pending)
Companion diagnostic tests: ALK BCR-ABL BRAF BRCA1 BRCA2 EGFR FGFR FLT3 HER2-breast HER2-stomach GEJ IDH1 IDH2 (pending) KIT KRAS MET MMR: ( MLH1 MSH2 MSH6 PMS2) PARP PDGFRB (pending) PDL1 22C3 PDL1 SP142 PDL1 SP263 (pending) PIK3CA RET ROS1 TMB (tumor mutational burden) (pending)
Associated drugs sorted by general drug name Afatinib / Gilotrif® Bevacizumab / Avastin® Bexarotene / Targretin® Brentuximab / Adcetris® Ceritinib / Zykadia® (pending) Cetuximab / Erbitux® Cobimetinib / Cotellic® (pending) Crizotinib / Xalkori® Dabrafenib / Tafinlar® Durvalumab / Imfinzi® Erlotinib / Tarceva® Gefitinib / Iressa® (pending) Gemcitabine / Gemzar® Imatinib mesylate / Gleevec® Lapatinib ditosylate / Tykerb® Larotrectinib / Vitrakvi® Olaparib / Lynparza® Osimertinib / Tagrisso® (pending) Panitumumab / Vectibix® Pembrolizumab / Keytruda® Pertuzumab / Perjeta® Rituximab / Rituxan® Rucaparib / Rubraca® (pending) Sorafenib tosylate / Nexavar® Sipuleucel-T / Provenge® Sunitinib malate / Sutent® Trametinib / Mekinist ® Trastuzumab / Herceptin® Vandetanib / Caprelsa® Veliparib (pending) Vemurafenib / Zelboraf® Vismodegib / Eviredge® Yttrium 90 microspheres
Associated drugs sorted by trade name Adcetris® Avastin® Caprelsa® Cotellic® (pending) Erbitux® Eviredge® Gemzar® Gilotrif® Gleevec® Herceptin® Imfinzi® Iressa® (pending) Keytruda® Lynparza® Mekinist ® Nexavar® Perjeta® Provenge® Rituxan® Rubraca® (pending) Sutent® Tafinlar® Tagrisso® (pending) Tarceva® Targretin® Tykerb® Vectibix® Vitrakvi® Xalkori® Yttrium 90 microspheres Zelboraf® Zykadia® (pending)
Superpages: entire chapter images virtual slides
Sites with companion diagnostic testing algorithms: breast colorectal (pending) gastric & esophageal (pending) lung ovary (pending) skin (melanoma) (pending)
Companion diagnostic tests: ALK BCR-ABL BRAF BRCA1 BRCA2 EGFR FGFR FLT3 HER2-breast HER2-stomach GEJ IDH1 IDH2 (pending) KIT KRAS MET MMR: ( MLH1 MSH2 MSH6 PMS2) PARP PDGFRB (pending) PDL1 22C3 PDL1 SP142 PDL1 SP263 (pending) PIK3CA RET ROS1 TMB (tumor mutational burden) (pending)
Associated drugs sorted by general drug name Afatinib / Gilotrif® Bevacizumab / Avastin® Bexarotene / Targretin® Brentuximab / Adcetris® Ceritinib / Zykadia® (pending) Cetuximab / Erbitux® Cobimetinib / Cotellic® (pending) Crizotinib / Xalkori® Dabrafenib / Tafinlar® Durvalumab / Imfinzi® Erlotinib / Tarceva® Gefitinib / Iressa® (pending) Gemcitabine / Gemzar® Imatinib mesylate / Gleevec® Lapatinib ditosylate / Tykerb® Larotrectinib / Vitrakvi® Olaparib / Lynparza® Osimertinib / Tagrisso® (pending) Panitumumab / Vectibix® Pembrolizumab / Keytruda® Pertuzumab / Perjeta® Rituximab / Rituxan® Rucaparib / Rubraca® (pending) Sorafenib tosylate / Nexavar® Sipuleucel-T / Provenge® Sunitinib malate / Sutent® Trametinib / Mekinist ® Trastuzumab / Herceptin® Vandetanib / Caprelsa® Veliparib (pending) Vemurafenib / Zelboraf® Vismodegib / Eviredge® Yttrium 90 microspheres
Associated drugs sorted by trade name Adcetris® Avastin® Caprelsa® Cotellic® (pending) Erbitux® Eviredge® Gemzar® Gilotrif® Gleevec® Herceptin® Imfinzi® Iressa® (pending) Keytruda® Lynparza® Mekinist ® Nexavar® Perjeta® Provenge® Rituxan® Rubraca® (pending) Sutent® Tafinlar® Tagrisso® (pending) Tarceva® Targretin® Tykerb® Vectibix® Vitrakvi® Xalkori® Yttrium 90 microspheres Zelboraf® Zykadia® (pending)
Superpages: entire chapter images virtual slides
Companion diagnostic testing books
Kim: 2019
Trøst Jørgensen: 2019
Find related Pathology books: molecular, oncology
